Coppersmith Brockelman Guides Arizona Employers in Updating Marijuana Testing Policies

Coppersmith Brockelman Guides Arizona Employers in Updating Marijuana Testing Policies

With recreational marijuana sales now underway in Arizona, many employers have questions about how it will affect their ability to maintain safe, drug-free workplaces. To help them understand their rights, Coppersmith Brockelman’s team of experienced employment law attorneys issued a Coppersmith Brief outlining practical testing considerations aligned with Arizona Law, as well as how employers can protect themselves from litigation. Well-versed in Arizona’s marijuana and drug testing laws, Coppersmith Brockelman can answer questions and assist with policy review and development, including updating employee handbooks and notices as well as notifications for prospective employees. Recognized by Chambers USA and ranked among 2021 Best Law Firms by Best Lawyers® and U.S. News & World Report, Coppersmith Brockelman’s employment law practice has a reputation for professional excellence and consistently impressive...

Read MoreRead More
Melissa Soliz and Erin Dunlap Discuss Healthcare Records Access During State Bar of Arizona’s Workers’ Compensation Program

Melissa Soliz and Erin Dunlap Discuss Healthcare Records Access During State Bar of Arizona’s Workers’ Compensation Program

Melissa Soliz and Erin Dunlap recently shared their expertise in health care data privacy in a presentation to fellow lawyers at the State Bar of Arizona’s annual Workers’ Compensation Program in Prescott.  The presentation began with an overview of HIPAA, breaking down relevant HIPAA exceptions related to workers’ compensation cases. Mel and Erin then provided historical background on 42 C.F.R. Part 2, which regulates substance use disorder records, explaining how to determine if Part 2 applies to workers’ compensation issues. They also touched on considerations related to state privacy laws and shared case examples to illustrate how a real workers’ compensation situation could play out. The presentation triggered interesting dialogue among the attendees, highlighting the importance of this topic in the worker’s compensation context.    Melissa focuses her practice on...

Read MoreRead More

Andy Gordon Discusses the Impact of Trump’s Border Wall with CBS 5

As President Trump asserts that a wall will reduce drug trafficking and illegal immigration across the Southwestern border, CBS 5 called upon Andy Gordon to discuss the potential impact of such a wall. Recent discoveries by Mexican police have confirmed that drug smugglers have tunneled beneath the 25-foot border fence in Nogales, Mexico, circumventing the wall altogether. Others hide drugs in produce shipments and drive them through ports of entry. In Yuma, footage has surfaced of people jumping the fence. Andy notes that the areas where a border wall would be most effective already have a fence in place. The remaining land is mostly privately-owned land that the government would need to confiscate via lengthy legal proceedings. He says that while a wall seems like a logical solution, it won’t halt drug trafficking, crime, or immigration, and...

Read MoreRead More

Kristen Rosati Helps Develop Key Programming for Attorneys Who Guide Nation’s Leading Teaching Hospitals

A recognized national leader in health care law, Partner Kristen Rosati was tapped by the American Health Lawyers Association (AHLA) to serve on the prestigious planning committee for the Academic Medical Centers and Teaching Hospitals Institute program, co-sponsored with the National Association of College and University Attorneys and the Association of American Medical Colleges. Held January 24-25 in Washington, DC, this annual event addressed legal issues unique to teaching hospitals and academic medical centers, attracting top in-house and outside counsel who advise the nation's leading teaching hospitals. The planning committee was tasked with content programming, including in-depth sessions covering privacy and security, GDPR, fraud and abuse, research, and emerging issues such as biologics, marijuana research, and innovation. Appointed by the AHLA President-Elect, this is the third year that Kristen has served on the planning committee. She is a...

Read MoreRead More

Melissa Soliz Breaks Down SAMHSA’s 42 C.F.R. Part 2 Supplemental Final Rule for Health Care Organizations

On January 3, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a Supplemental Final Rule (SFR), which amended the federal Confidentiality of Substance Use Disorder Patient Records regulations at 42 C.F.R. Part 2. These revisions will make it easier for general hospitals, primary care providers and other non-Part 2 Programs that hold protected substance use disorder information to share that information with their contractors, subcontractors, legal representatives, and auditors for payment and health care operations activities. The SFR goes into effect on February 2, 2018, with the exception of new contract requirements that must be implemented by February 2, 2020. Coppersmith Brockelman’s Melissa Soliz (with the assistance of Kristen Rosati and affiliated attorney Erin Dunlap) summarizes those changes and provides a chart comparing the...

Read MoreRead More

Kristen Rosati and Melissa Soliz Share Expertise in Privacy Compliance for Human Subjects Research with Bloomberg Law

Coppersmith Brockelman’s Kristen Rosati and Melissa Soliz co-authored a piece for Bloomberg Law’s Privacy and Data Security, sharing an overview of the privacy compliance issues associated with the use and disclosure of health information in human subjects research. They discuss complying with the Health Information Portability and Accountability Act (HIPAA), the Common Rule, FDA regulations and federal and state health confidentiality laws in all stages of the research process. The piece includes a variety of samples and templates for forms, contracts, and agreements for human subjects research. Kristen is one of the nation’s leading HIPAA compliance attorneys, with deep experience in data breaches, health information exchange, data sharing for research and clinical integration initiatives, clinical research compliance, clinical trials contracting, biobanking and genomic privacy, and all things...

Read MoreRead More